About Sol-gel (SLGL)
Sol-Gel Technologies Ltd operates as a clinical stage pharmaceutical company. The Company identifies and develops topical dermatological drug products for the treatment of skin diseases. Sol-Gel Technologies markets its products worldwide.
- USD7.45
- USD7.85
- USD7.40
- USD16.50
- 76.40%
- 15.40k
- 72.41k
- 20M
- 3.34
- 5.40%
Stock News
4 hours ago
Obsidian Energy Ltd. (OBE) Q1 2025 Earnings Call Transcript
SeekingAlpha
yesterday
Ras Baraka arrest: Trump administration eyes charging three more NJ Democrats in ICE fracas
CNBC
yesterday
The case for owning stocks at every age, plus what the Street means by 'risk off'
CNBC
yesterday
I pay $4,000 a month for rent in Manhattan. Should I be paying for a mortgage instead?
MarketWatch
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
